All News

This is how I became hospital property.

The community of patients and caregivers supports us through our cancer journey.

Better treatment and follow-up are being credited with a reduction in the likelihood that survivors of childhood cancers will later die of illnesses caused by their therapy, such as new malignancies or cardiac or lung disease.

When cancers that originate elsewhere cause small metastases in the brain, initial treatment should not routinely be followed by whole brain radiation therapy, because that strategy dramatically increases the chances of cognitive decline without improving survival outcomes.

Adding the chemotherapy docetaxel to standard combination hormonal and radiation therapy boosted survival rates in patients with high-risk localized prostate cancer, according to a study.

The American Society of Clinical Oncology is testing what will happen if patients are treated according to the genomics of their tumors, rather than on the basis of their disease types, such as breast or colorectal cancers.

An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.

Research presented at ASCO shows late effects of childhood cancer treatment lessening.

It is my five-year breast cancer anniversary and I will celebrate because I am here.

Removing lymph nodes in the neck before they are affected by oral squamous cell cancer is a life-saving measure and should be adopted as a new standard in treating the disease, according to the results of a phase 3 study.

Adding the targeted drug Imbruvica to a standard combination treatment reduced the risk of disease progression by 80 percent compared with the standard combination alone in patients with pretreated CLL or SLL.

Data from a new report that shows compelling information on physicians who use Twitter, types of cancer, and ways to assess integrity.

By adding the targeted drug Ibrance to the hormonal drug Faslodex, women with previously treated hormone receptor (HR)-positive, HER2-negative breast cancer delayed disease progression by more than five months.

I returned from Mayo about 10 days ago and my ‘scanxiety' has been finally ameliorated.

Patients with relapsed indolent non-Hodgkin lymphoma who took the anti-CD20 agent Gazyva with Treanda, rather than Treanda alone, doubled their time until further disease progression during the phase 3 GADOLIN study.

Patients with heavily pretreated colorectal cancer who harbored genetic defects in DNA mismatch repair (MMR) experienced high response rates when treated with the PD-1 inhibitor Keytruda (pembrolizumab) in a recent study.

The immunotherapy Opdivo (nivolumab) has been shown to convey an overall survival (OS) benefit superior to that offered by the chemotherapy docetaxel in both nonsquamous and squamous non–small cell lung cancer (NSCLC).

The immunotherapy Keytruda (pembrolizumab), in a recent study, proved twice as effective for the treatment of head and neck cancer as Erbitux (cetuximab), the only targeted therapy indicated as a therapy for the disease.

This month marks my second anniversary of being diagnosed with stage 4 lung cancer, an event that profoundly changed my view of life and death.

In a new study, weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group.

Aug. 27, 2000, started as an ordinary day for Dellann Elliott Mydland. She and her husband Chris Elliott and their two children, then 5 and 8 years old, had just finished up a weekend at their cabin and were preparing to relax by the grill at home.

2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).

A breast cancer survivor shares ways she copes with fear of recurrence while waiting for her latest mammogram results.

Mending from cancer and its treatment takes time. It's not always easy to let your body set the pace for recovery.

Herceptin has been one of the most remarkable breakthroughs in treating breast cancer — but it can cause cardiac issues.

It's been 17 years since my diagnosis of stage 3a non–small cell lung cancer. I can remember that moment as if it was yesterday.

Twenty strokes signaled that there was trouble, though no one would have suspected a tumor.

We spend so much time making it look like we've got it all covered, when in reality, things are unraveling just below the surface. Maybe that's OK.